Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The LEADER trial enrolled patients with T2DM and high cardiovascular risk, defined as established CVD (81%) or age 60 years with at least one risk factor, and showed that liraglutide significantly reduced the incidence of 3-point major adverse cardiovascular events (MACE) (i.e., CV death, non-fatal myocardial infarction, non-fatal stroke) by 13% compared to placebo (HR 0.87
At BUBS Naturals, we are driven by more than just supplements
Its efficacy in promoting significant weight reduction has been backed by numerous scientific trials, providing hope for many struggling with obesity
At 5mg/mL, it equals 5 units
"Evaluation of metabolically stabilized angiotensin IV analogs." J Pharmacol Exp Ther
US$ 21.09
US$ 22.02
US$ 22.24
US$ 23.72
US$ 24.44
